Business Description
Beihai Gofar Chuanshan Biological Co Ltd
NAICS : 325414
SIC : 2836
ISIN : CNE000001DD2
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.79 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 9.93 | |||||
Beneish M-Score | -2.82 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.9 | |||||
3-Year Book Growth Rate | 0.2 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.86 | |||||
9-Day RSI | 26.29 | |||||
14-Day RSI | 36.94 | |||||
6-1 Month Momentum % | 25.06 | |||||
12-1 Month Momentum % | 8.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.61 | |||||
Quick Ratio | 3.01 | |||||
Cash Ratio | 0.94 | |||||
Days Inventory | 117.25 | |||||
Days Sales Outstanding | 232.09 | |||||
Days Payable | 113.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | -0.21 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 25.22 | |||||
Operating Margin % | -5.45 | |||||
Net Margin % | -25.04 | |||||
FCF Margin % | -7.62 | |||||
ROE % | -10.02 | |||||
ROA % | -8.32 | |||||
ROIC % | -2.54 | |||||
ROC (Joel Greenblatt) % | -29.13 | |||||
ROCE % | -9.16 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.82 | |||||
PB Ratio | 2.91 | |||||
Price-to-Tangible-Book | 4.03 | |||||
EV-to-EBIT | -28.83 | |||||
EV-to-EBITDA | -28.83 | |||||
EV-to-Revenue | 6.73 | |||||
EV-to-FCF | -88.31 | |||||
Price-to-Projected-FCF | 4.8 | |||||
Price-to-Median-PS-Value | 0.94 | |||||
Price-to-Net-Current-Asset-Value | 7.38 | |||||
Earnings Yield (Greenblatt) % | -3.47 | |||||
FCF Yield % | -1.08 | |||||
Forward Rate of Return (Yacktman) % | -23.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Beihai Gofar Chuanshan Biological Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 349.368 | ||
EPS (TTM) (Â¥) | -0.17 | ||
Beta | 0.49 | ||
Volatility % | 48.39 | ||
14-Day RSI | 36.94 | ||
14-Day ATR (Â¥) | 0.262352 | ||
20-Day SMA (Â¥) | 5.308 | ||
12-1 Month Momentum % | 8.62 | ||
52-Week Range (Â¥) | 2.9 - 5.8 | ||
Shares Outstanding (Mil) | 524.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Beihai Gofar Chuanshan Biological Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Beihai Gofar Chuanshan Biological Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Beihai Gofar Chuanshan Biological Co Ltd Frequently Asked Questions
What is Beihai Gofar Chuanshan Biological Co Ltd(SHSE:600538)'s stock price today?
When is next earnings date of Beihai Gofar Chuanshan Biological Co Ltd(SHSE:600538)?
Does Beihai Gofar Chuanshan Biological Co Ltd(SHSE:600538) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |